Rare diseases
Investigational molecules
Locations
100 King Street West, L8P 1A2
Research activity includes peripheral arterial disease and broader prevention of major cardiovascular events, with interest in reducing myocardial infarction, stroke, and severe limb complications. The portfolio also extends to heart failure linked to ischaemic heart disease.
Additional focus is placed on therapies aimed at limiting residual vascular risk and preventing progression to serious arterial outcomes.
Hamilton Health Sciences Corporation runs clinical trials in conditions such as Atrial fibrillation, Haemorrhage intracranial, Peripheral arterial occlusive disease, Intermittent claudication, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Belgium
ItalyBelgium
GermanyBelgiumItalyBelgium
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
